» Articles » PMID: 38854988

First Report of Amphotericin B Resistant Isolated from the ICU of a Referral Hospital in Indonesia

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Amphotericin B is a broad-spectrum antifungal agent commonly used to treat infection. was isolated from patients reported to be intrinsically resistant to amphotericin B, encoded by the ERG2 and ERG11 genes. However, there have been limited studies concerning amphotericin B-resistant in Indonesia. The objective of this study is to explore the phenotypic and genotypic characteristics (ERG2 and ERG11) of isolated from the ICU of a referral hospital in Indonesia.

Materials And Methods: Identification and susceptibility tests were conducted using VITEK2. Thereafter, DNA was extracted and amplified using conventional PCR followed by DNA sequencing (Sanger method).

Results: The results of the phenotypic susceptibility test showed that all were resistant to amphotericin B. ERG2 and ERG11 sequences showed the same amino acid sequence and corresponded to references that are resistant to amphotericin B.

Conclusion: The resistant properties of against amphotericin B found in this study require further exploration, including comparing resistant and sensitive to amphotericin B. In addition, it is necessary to analyze other genes besides ERG2 and ERG11.

Citing Articles

The multidrug-resistant complex and phylogenetic related species: Insights into antifungal resistance mechanisms.

Ramos L, Barbosa P, Lorentino C, Lima J, Braga A, Lima R Curr Res Microb Sci. 2025; 8:100354.

PMID: 39995443 PMC: 11847750. DOI: 10.1016/j.crmicr.2025.100354.

References
1.
Zhang H, Niu Y, Tan J, Liu W, Sun M, Yang E . Global Screening of Genomic and Transcriptomic Factors Associated with Phenotype Differences between Multidrug-Resistant and -Susceptible Candida haemulonii Strains. mSystems. 2019; 4(6). PMC: 6918027. DOI: 10.1128/mSystems.00459-19. View

2.
Kim E, Lee E, Kwak Y, Yoo H, Choi J, Kim S . Trends in the Epidemiology of Candidemia in Intensive Care Units From 2006 to 2017: Results From the Korean National Healthcare-Associated Infections Surveillance System. Front Med (Lausanne). 2021; 7:606976. PMC: 7773785. DOI: 10.3389/fmed.2020.606976. View

3.
Ramos L, Figueiredo-Carvalho M, Barbedo L, Ziccardi M, Chaves A, Zancope-Oliveira R . Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother. 2014; 70(1):111-5. DOI: 10.1093/jac/dku321. View

4.
Lima S, Francisco E, de Almeida Junior J, Wagner de Castro Lima Santos D, Carlesse F, Queiroz-Telles F . Increasing Prevalence of Multidrug-Resistant Species Complex among All Yeast Cultures Collected by a Reference Laboratory over the Past 11 Years. J Fungi (Basel). 2020; 6(3). PMC: 7558365. DOI: 10.3390/jof6030110. View

5.
Piedrahita C, Cadnum J, Jencson A, Shaikh A, Ghannoum M, Donskey C . Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species. Infect Control Hosp Epidemiol. 2017; 38(9):1107-1109. DOI: 10.1017/ice.2017.127. View